The next big milestone of the U.S. Drug Supply Chain Security Act (DSCSA) is approaching fast. Wholesale distributors must verify returned pharmaceuitcal products before they can be resold.
With around 60 million pharmaceutical saleable returns in the US market every year, solutions must be able to handle the high volume of saleable returns that need to be verified. Additionally, wholesale distributors need an easy-to-use and simple-to-configure scanning solution that provides real-time feedback on the product’s authenticity after each scan to minimize operational impacts.
However, many wholesale distributors currently rely on point-to-point solutions or even on manual processes to verify their saleable returns products, lacking real-time feedback and significantly impacting the efficiency of wholesale distributors’ warehouse and business processes.
With Movilitas.Cloud’s out-of-box VRS solution pharmaceutical wholesale distributors and manufacturers can easily meet the saleable returns verification requirement that the DSCSA specifies. The solution streamlines the bi-directional data flow between manufacturers and wholesale distributors and provides real-time feedback.
